Drug Profile
M 7040
Alternative Names: M7040; M7040BLatest Information Update: 18 Oct 2021
Price :
$50
*
At a glance
- Originator Galderma
- Developer Maruho
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Dermatitis
Most Recent Events
- 11 Oct 2021 Maruho completes a phase III clinical trials in Dermatitis in Japan (Topical), prior to October 2021 (Maruho website, October 2021)
- 11 Oct 2021 Phase III development is ongoing in Japan (Maruho pipeline, September 2020)